| NDVIX | VISVX | NDVIX / VISVX | |
| Total Expense Ratio | 0.96 | 0.19 | 505% |
| Annual Report Gross Expense Ratio | 0.97 | 0.19 | 511% |
| Fund Existence | 15 years | 28 years | - |
| Gain YTD | 5.592 | 5.354 | 104% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.75B | 59.8B | 5% |
| Annual Yield % from dividends | 1.27 | 1.84 | 69% |
| Returns for 1 year | -1.36 | 12.23 | -11% |
| Returns for 3 years | 2.46 | 34.31 | 7% |
| Returns for 5 years | 5.16 | 51.12 | 10% |
| Returns for 10 years | 75.23 | 161.21 | 47% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSVIX | 5.29 | 0.04 | +0.76% |
| MetLife Small Company Equity Inst | |||
| SCSIX | 38.95 | 0.21 | +0.54% |
| Sterling Capital SmCp Val R6 | |||
| JEPRX | 14.50 | 0.03 | +0.21% |
| JPMorgan Equity Premium Income R6 | |||
| JFARX | 36.77 | -0.09 | -0.24% |
| JHancock Fundamental All Cap Core R4 | |||
| RCGTX | 14.20 | -0.25 | -1.73% |
| Virtus Zevenbergen Technology C | |||